Selection Criteria

All applications will be reviewed on the following criteria:
• Curatorial strength of the gallery exhibition programme.
• Artists from the BRICS region are preferred. This refers to artists from Latin America, Africa. Central Asia and Caucasus, South, and Northeast Asia as well as South East Asia.
• Preference will be given to those galleries featuring well-established and well-represented artists in the auction market.
• Artists presented by other galleries will not be considered again.

REGISTRATION OVERVIEW

EMERGING CLINICAL TRIAL HUBS IN EECCA

Georgia, Ukraine, Armenia, and Uzbekistan are rapidly establishing themselves as pivotal hubs in the clinical trial landscape of Eastern Europe, Caucasus, and Central Asia (EECCA). These regions offer unparalleled advantages, driven by cost-effective environments, rapid patient recruitment to skilled investigators and diverse patient populations. Their growing research infrastructures, streamlined regulatory processes, and strong government support make them ideal destinations for advancing trials in therapeutic areas such as oncology, infectious diseases, and rare genetic disorders.

Join us for an insightful webinar and hear from leading regulators, global pharmaceutical companies, biotech firms, and CROs. Gain invaluable insights into the regulatory landscape, explore opportunities and challenges for patient recruitment, and discover actionable solutions to navigate the complexities of these markets while driving inclusivity in global clinical research.



📅 Date: Tuesday, March 18
Time: 3 PM - 5 PM GMT
📍 Location: Online

Don't miss the chance to be part of this transformative conversation that shapes the future of clinical trials in EECCA.

INDIVIDUAL Details

register now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form